Journal article
Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Abstract
There is an independent progressive epidemiologic relation between glycemia and cardiovascular disease (CVD) events; however, whether lowering glucose levels with currently available therapies can reduce CVD events remains unknown. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial is designed to answer this question in high-risk patients with type 2 diabetes mellitus. In ACCORD, 10,251 patients with type 2 diabetes and other …
Authors
Gerstein HC; Riddle MC; Kendall DM; Cohen RM; Goland R; Feinglos MN; Kirk JK; Hamilton BP; Ismail-Beigi F; Feeney P
Journal
The American Journal of Cardiology, Vol. 99, No. 12, pp. s34–s43
Publisher
Elsevier
Publication Date
June 2007
DOI
10.1016/j.amjcard.2007.03.004
ISSN
0002-9149